palmidrol has been researched along with glucagon-like peptide 1 in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Barrett, DG; Beavers, LS; Bokvist, K; Bui, HH; Chesterfield, AK; Efanov, AM; Farb, TB; Ficorilli, J; Kuo, MS; Syed, SK | 1 |
1 other study(ies) available for palmidrol and glucagon-like peptide 1
Article | Year |
---|---|
Regulation of GPR119 receptor activity with endocannabinoid-like lipids.
Topics: Amides; Animals; Cannabinoid Receptor Agonists; Cannabinoid Receptor Antagonists; Cell Line; Endocannabinoids; Endocrine Cells; Ethanolamines; Fasting; Glucagon-Like Peptide 1; Glycerides; Humans; Intestinal Mucosa; Male; Mice; Mice, Inbred C57BL; Oleic Acids; Organ Specificity; Palmitic Acids; Random Allocation; Receptors, G-Protein-Coupled; Recombinant Proteins; Thinness; Up-Regulation | 2012 |